Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over the United States' request for confidential information.
The decision came to light after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
A government spokesperson later explained that the US was demanding access to health data for research and profit but was unwilling to guarantee the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable process of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged further dialogue to secure a agreement suitable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court halted a similar deal with the US following concerns were raised about the safety of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and responsibility.
As per statements, Sixteen African countries have so far agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data indefinitely, without any corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," he stated.
"In essence, our nation would supply the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our population if a new health crisis emerge."
National Interest and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems already set up through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."
These objections over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration could be structured in a manner that honours the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that talks need to persist since a large portion of the nation's Aids initiatives were funded by foreign aid.
"In cases where technical issues exist, such as those involving data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," it added.
The situation underscores the complex tensions between accepting crucial international aid and protecting local interests in an increasingly interconnected world.